INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer

Published on : Published by : BioBuzz Media

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases and treat people with cancer and HPV-associated diseases, today announced the appointment of Dr. Michael Sumner, MB BS, MBA, as Chief Medical Officer (CMO). Dr. Sumner will oversee INOVIO’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, as well as regulatory affairs, pharmacovigilance and medical affairs. He will serve on the company’s executive leadership team and will report to INOVIO’s President and Chief Executive Officer, Dr. Jacqueline Shea.

5 Questions with Jason Bosiacki, Associate Director, Manufacturing Operations at NextCure

Published on : Published by : BioBuzz Media

Jason received his bachelor’s degree in biology with a minor in chemistry from Frostburg State University. He has been in the biotech industry for 12 years, having spent most of that time in R&D, primarily immunology and in the manufacturing of biologics, making monoclonal antibodies and fusions proteins.

American Gene Technologies Appoints Dr. Jeff Boyle as Chief Science Officer

Published on : Published by : BioBuzz Media

American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer. Dr. Boyle comes to the post with deep biotechnology expertise which will help further accelerate the company’s FDA-approved HIV gene therapy clinical trial that expects to see first indications of efficacy in Q3, as well as continue the developments in monogenic disease and immuno-oncology. 

5 Questions with Michael Doub, Laboratory Director at Eastern Analytical Labs

Published on : Published by : BioBuzz Media

Michael Doub has enjoyed a diverse professional path working in both the life sciences and manufacturing. Before coming to Eastern Analytical Labs, Michael co-founded Aireon Therapeutics Inc. where he served as CEO.  Michael has a successful record of building operational systems and high performing teams that drive organizational growth from concept to commercialization.  He has received a BA in Biology from Hood College, an MBA from University of Maryland and Operational Efficiency Certifications from Villanova University.

Tanner Ash joins BioNTech as Senior Specialist, Quality Assurance Operations

Tanner-Ash
Published on : Published by : BioBuzz Media

Tanner Ash recently joined BioNTech as Senior Specialist, Quality Assurance Operations. Tanner was most recently a Supervisor at Ellume, a global diagnostics company that develops, manufactures, and commercializes the next generation of digitally enabled diagnostic products for healthcare professionals and consumers.

In addition to his work with Ellume, over the past decade Tanner has held positions with Kite, VaLogic, and Lonza.

Brian Stamper Appointed Vice President, Cell Therapy Operations at Immunomic Therapeutics

Published on : Published by : BioBuzz Media

Brian Stamper recently joined Immunomic Therapeutics, Inc. as Vice President, Cell Therapy Operations. Brian has over 20 years of experience in the biopharmaceutical industry, including increasingly responsible management positions in various operational areas including cell therapy operations, biotechnology manufacturing, and process engineering.

5 Questions With Scott Pecor, Biomanufacturing Professional

Published on : Published by : BioBuzz Media

Scott is detail-oriented, conscientious, and highly skilled at his craft, with 16+ years of experience working in a GMP environment, delivering high-impact results through an effective combination of fine-tuned technology/technical expertise, acute attention to detail, troubleshooting skills, seamless project management, and interpersonal communication techniques. He is a technology enthusiast who strives for perfection and is effective at multitasking in a highly dynamic, challenging, and fast-changing environment while juggling multiple priorities simultaneously and remaining focused.

My Career Journey: Alexis Staten, Life Sciences Recruiter at Workforce Genetics

Published on : Published by : Steven Surdez

Former lab scientist Alexis Staten recently joined Workforce Genetics (WFGX) as a Life Sciences Recruiter. Alexis brings a unique background in customer service and lab experience to her new role. She joins an experienced, growing biopharma talent recruiting team at Workforce Genetics and joins Paul Streng, another recent hire, as a former scientist turned life sciences recruiter.